β-Secretase inhibition for the treatment of Alzheimer's disease – promise and challenge
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (2) , 92-97
- https://doi.org/10.1016/j.tips.2003.12.004
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Antagonistic Effects of β-Site Amyloid Precursor Protein-cleaving Enzymes 1 and 2 on β-Amyloid Peptide Production in CellsJournal of Biological Chemistry, 2003
- BACE1- and BACE2-expressing Human Cells: CHARACTERIZATION OF β-AMYLOID PRECURSOR PROTEIN-DERIVED CATABOLITES, DESIGN OF A NOVEL FLUORIMETRIC ASSAY, AND IDENTIFICATION OF NEW IN VITRO INHIBITORSPublished by Elsevier ,2003
- Characterization of α2,6-Sialyltransferase Cleavage by Alzheimer's β-Secretase (BACE1)Journal of Biological Chemistry, 2003
- Pharmacological Knock-down of the Presenilin 1 Heterodimer by a Novel γ-Secretase InhibitorJournal of Biological Chemistry, 2001
- Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)Journal of Medicinal Chemistry, 2001
- Subsite Specificity of Memapsin 2 (β-Secretase): Implications for Inhibitor DesignBiochemistry, 2001
- A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor ProteinPublished by Elsevier ,2001
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- BACE Maps to Chromosome 11 and a BACE Homolog, BACE2 , Reside in the Obligate Down Syndrome Region of Chromosome 21Science, 1999
- Alzheimer's disease amyloid precursor protein (ApPP): proteolytic processing, secretases and βA4 amyloid productionAmyloid, 1994